Buserelin

Jump to: navigation, search


Buserelin.svg
Buserelin
Systematic (IUPAC) name
 ?
Identifiers
CAS number 57982-77-1
ATC code L02AE01
PubChem 50225
DrugBank HMDB03170
Chemical data
Formula C62H90N16O15 
Mol. mass 1299.48 g/mol
Synonyms D-Ser(Tbu)6EA10LHRH
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life 72 to 80 minutes
Excretion Renal
Therapeutic considerations
Pregnancy cat.

X

Legal status

℞-only

Routes implant, intranasal

WikiDoc Resources for

Buserelin

Articles

Most recent articles on Buserelin

Most cited articles on Buserelin

Review articles on Buserelin

Articles on Buserelin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Buserelin

Images of Buserelin

Photos of Buserelin

Podcasts & MP3s on Buserelin

Videos on Buserelin

Evidence Based Medicine

Cochrane Collaboration on Buserelin

Bandolier on Buserelin

TRIP on Buserelin

Clinical Trials

Ongoing Trials on Buserelin at Clinical Trials.gov

Trial results on Buserelin

Clinical Trials on Buserelin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Buserelin

NICE Guidance on Buserelin

NHS PRODIGY Guidance

FDA on Buserelin

CDC on Buserelin

Books

Books on Buserelin

News

Buserelin in the news

Be alerted to news on Buserelin

News trends on Buserelin

Commentary

Blogs on Buserelin

Definitions

Definitions of Buserelin

Patient Resources / Community

Patient resources on Buserelin

Discussion groups on Buserelin

Patient Handouts on Buserelin

Directions to Hospitals Treating Buserelin

Risk calculators and risk factors for Buserelin

Healthcare Provider Resources

Symptoms of Buserelin

Causes & Risk Factors for Buserelin

Diagnostic studies for Buserelin

Treatment of Buserelin

Continuing Medical Education (CME)

CME Programs on Buserelin

International

Buserelin en Espanol

Buserelin en Francais

Business

Buserelin in the Marketplace

Patents on Buserelin

Experimental / Informatics

List of terms related to Buserelin

Buserelin is a Gonadotropin-releasing hormone agonist (GnRH agonist). By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Like other GnRH agonists, buserelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction.

It is normally delivered via a nasal spray but is also available as an injection.

Buserelin acetate is marketed by Sanofi-Aventis under the brand name Suprefact.

de:Buserelin

sv:Buserelinacetat



Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox